These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

417 related items for PubMed ID: 3715090

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [131I-meta-iodobenzylguanidine (MIBG) for the detection and therapy of pheochromocytoma and neuroblastoma].
    Nakajo M, Shinohara S.
    Rinsho Hoshasen; 1987 Apr; 32(4):461-70. PubMed ID: 3613180
    [No Abstract] [Full Text] [Related]

  • 11. Limitations of 131I-MIBG scintigraphy in locating pheochromocytomas.
    Gough IR, Thompson NW, Shapiro B, Sisson JC.
    Surgery; 1985 Jul; 98(1):115-20. PubMed ID: 2861667
    [Abstract] [Full Text] [Related]

  • 12. Thallium-201 scintigraphy in the diagnosis of pheochromocytoma.
    Wenisch HJ, Maul FD, Happ J, Schumm PM, Bittner G, Wanner U, Hör G, Encke A.
    Cardiology; 1985 Jul; 72 Suppl 1():150-2. PubMed ID: 4053122
    [Abstract] [Full Text] [Related]

  • 13. Meta-[131I]iodobenzylguanidine in the scintigraphic evaluation of neural crest tumors.
    Zagar I, Han R, Mitrovic S.
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):13-6. PubMed ID: 9002742
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [131I-meta-iodobenzylguanidine scintigraphy in patients with a suspected pheochromocytoma. A comparison with CT and biohumoral parameters].
    Maurelli L, Cuocolo A, Lastoria S, Brunetti A, Maurea S, Lembo G, Klain M, Caracò C, Salvatore M.
    Radiol Med; 1991 Dec; 82(6):839-43. PubMed ID: 1788441
    [Abstract] [Full Text] [Related]

  • 16. Imaging of catecholamine-secreting tumours: uses of MIBG in diagnosis and treatment.
    Shapiro B.
    Baillieres Clin Endocrinol Metab; 1993 Apr; 7(2):491-507. PubMed ID: 8489488
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The normal and abnormal distribution of the adrenomedullary imaging agent m-[I-131]iodobenzylguanidine (I-131 MIBG) in man: evaluation by scintigraphy.
    Nakajo M, Shapiro B, Copp J, Kalff V, Gross MD, Sisson JC, Beierwaltes WH.
    J Nucl Med; 1983 Aug; 24(8):672-82. PubMed ID: 6135764
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.